Hunger Hormones
Binge Eating and Appetite Signals
Binge eating is distinct from ordinary overeating, with its own recognisable pattern and appetite signalling disruption....
Women with polycystic ovary syndrome are frequently told to lose weight, and frequently find it considerably harder than they are led to expect.
That difficulty is real and physiological rather than a lack of effort. Understanding why explains where treatment actually helps.
What PCOS involves
PCOS is a hormonal condition affecting a substantial proportion of women of reproductive age. Its features vary, but the common elements are:
Irregular or absent ovulation, producing irregular, infrequent or absent periods.
Elevated androgens, which can cause acne, excess facial or body hair, and scalp hair thinning.
Polycystic ovaries on ultrasound, meaning multiple small follicles rather than genuine cysts.
Insulin resistance, present in a large share of cases including in women who are not overweight.
That last feature is the one that matters most for weight, and it is frequently the least explained.
Why weight loss is harder with PCOS
Insulin resistance means your cells respond poorly to insulin, so your pancreas produces more to compensate. Higher circulating insulin promotes fat storage, particularly around the abdomen, and makes stored fat harder to release.
High insulin drives androgen production. The ovaries produce more testosterone under insulin stimulation, which worsens the other PCOS features.
Androgens promote abdominal fat storage, which further worsens insulin resistance.
Each element reinforces the others. That is the cycle, and it is why standard advice to eat less and move more delivers less than expected.
The frustration many women describe is not imagined. The same effort produces less result.
Where weight loss interrupts it
The cycle also works in reverse, which is the encouraging part.
Weight reduction improves insulin sensitivity. Lower insulin means lower androgen production. Lower androgens allow follicle development to normalise. Ovulation resumes.
Research consistently shows meaningful improvement at 5 to 10 percent weight reduction. Cycles become more regular, ovulation rates improve, and androgen-related symptoms ease.
On a 90 kg person that is roughly 4.5 to 9 kg. You do not need to reach an ideal weight, and expecting to before seeing any benefit causes people to give up early.
Why appetite medication is relevant here specifically
If the obstacle is a hormonal environment that promotes storage and increases appetite, then something acting on appetite addresses a genuine part of the problem.
GLP-1 pathway support reduces appetite and improves insulin sensitivity. Both matter in PCOS.
Metformin has been used in PCOS for years for the insulin resistance component specifically, and is prescribed by many gynaecologists here. That is a separate treatment decision belonging with your own doctor.
The fertility consequence
This deserves emphasis because it catches people out.
Many women with PCOS have concluded over years that conception is unlikely. Weight loss changes that, and ovulation frequently resumes before periods become visibly regular.
For someone trying to conceive, that is genuinely good news, and weight loss before pregnancy also improves outcomes.
For someone not trying, it is a change in risk that needs contraception adjusted to match. Assuming PCOS means low pregnancy risk is a mistake once weight starts falling.
Either way, the conversation belongs at the start of treatment. Our guide to GLP-1 drugs and birth control covers the contraceptive side, and weight loss and fertility covers the mechanism.
What about berberine
Berberine is widely recommended for PCOS online, and the evidence is worth stating accurately.
A systematic review and meta-analysis of berberine in PCOS examined its effects on reproduction and metabolism. Berberine does improve insulin resistance measures, which is a legitimate reason it appears in PCOS discussions.
What it does not do is produce meaningful weight loss. Pooled trial data across populations found no significant reduction in body weight.
So berberine may help the insulin resistance component. It is not a weight loss treatment, and anyone taking it expecting weight reduction will be disappointed. It also has real drug interactions and is unsafe in pregnancy, which matters for women who may be trying to conceive.
Cinnamon is also frequently suggested. A meta-analysis pooling five trials in PCOS found no significant effect on body weight or BMI.
The broader health stakes
PCOS is not only about periods and fertility.
It raises the risk of type 2 diabetes, and that risk is elevated further in South Asian populations who develop diabetes at lower BMI thresholds. WHO's obesity fact sheet sets out the wider consequences of excess weight, including cardiovascular disease.
Long-term risks also include endometrial changes from infrequent ovulation, and cardiovascular risk from the metabolic profile.
Addressing insulin resistance and weight is therefore about more than symptoms.
The Pakistani context
PCOS is common here and carries particular social weight because of the fertility dimension.
Women frequently receive the advice to lose weight without any explanation of why it is harder for them, which produces self-blame rather than progress. Many are not told that insulin resistance is central, or that 5 to 10 percent is the threshold that matters.
The hair thinning and facial hair that accompany elevated androgens also carry social cost that goes unacknowledged in clinical settings.
If you have PCOS and have struggled with weight, the useful first step is understanding that the difficulty is physiological. Doctor-reviewed appetite support in Pakistan works on the GLP-1 pathway as a physician-reviewed sublingual supplement with physician review before dispatch. METASLIM™ is not a pharmaceutical GLP-1 receptor agonist and does not treat PCOS.
What the review provides is someone establishing whether PCOS, thyroid disease or another cause is contributing, which changes what treatment makes sense. If you are unsure where you stand, take our weight loss quiz as a starting point.
The summary
PCOS involves insulin resistance that promotes fat storage and drives androgen production, which promotes further abdominal storage. The cycle reinforces itself.
Weight loss is genuinely harder with PCOS, and that difficulty is physiological rather than a failure of effort.
A 5 to 10 percent reduction improves cycles, ovulation rates and androgen symptoms in many women.
Ovulation frequently resumes before periods look regular, so contraception or conception planning belongs at the start.
Berberine improves insulin resistance measures but produced no significant weight loss in pooled trials. Cinnamon showed no significant weight effect in PCOS specifically.
PCOS raises long-term diabetes and cardiovascular risk, particularly in South Asian populations.
See if you qualify for the program and raise PCOS at the review.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.